Stevanato Group Reports Q1 2026 Earnings
Stevanato (STVN) reported first-quarter earnings for fiscal year 2026, with revenue of EUR 273.6 million and growth driven by the Biopharmaceutical and Diagnostic Solutions segment. The company noted a decline in Engineering Segment Revenue due to lower sales from assembly and glass conversion.
Topics: gross_profit_margin revenue segments